Login to Your Account



Ruiyi moves toward multiple IND filings with $15M series B

By Marie Powers
Staff Writer

Wednesday, April 2, 2014

With its feet planted on both sides of the Pacific Ocean and its ambitions nearly as wide, Ruiyi Inc. netted a $15 million series B round from its existing investors, which include 5AM Ventures, Versant Ventures, Apposite Capital, SR One, Merck Serono Ventures and Aravis SA.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription